Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study
BACKGROUND: Mature oocytes are prerequisite for achieving the process of in vitro fertilization. Human chorionic gonadotropin (hCG) is the standard trigger used for stimulating ovulation but is associated with ovarian hyperstimulation syndrome (OHSS). Gonadotropin-releasing hormone agonist trigger a...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Journal of Human Reproductive Sciences |
Subjects: | |
Online Access: | http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2016;volume=9;issue=2;spage=101;epage=106;aulast=Mahajan |
id |
doaj-12e77d4b35914e20b107ad405250da40 |
---|---|
record_format |
Article |
spelling |
doaj-12e77d4b35914e20b107ad405250da402020-11-25T01:30:18ZengWolters Kluwer Medknow PublicationsJournal of Human Reproductive Sciences0974-12081998-47662016-01-019210110610.4103/0974-1208.183506Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized studyNalini MahajanShilpa SharmaPuneet Rana AroraShalu GuptaKumkum RaniPadmaja NaiduBACKGROUND: Mature oocytes are prerequisite for achieving the process of in vitro fertilization. Human chorionic gonadotropin (hCG) is the standard trigger used for stimulating ovulation but is associated with ovarian hyperstimulation syndrome (OHSS). Gonadotropin-releasing hormone agonist trigger achieves oocyte maturation and lowers the incidence of OHSS, but it has limitations of higher pregnancy loss rate and miscarriage rates. Coadministration of both hormones is found to improve the pregnancy rates and the number of mature oocytes retrieved. We aimed to assess if the dual trigger is better than the conventional hCG in triggering oocyte maturation. METHODOLOGY: The study included 76 female patients aged 24–43 years who were randomly divided into two groups with 38 patients in each arm. The study included patients with antimullerian hormone (AMH) <4 ng/ml, antral follicle counts (AFCs)/ovary <12. The study excluded high responders-AMH >4 ng/ml and AFC/ovary >12 to avoid OHSS risk with hCG trigger. RESULTS: The study showed statistically insignificant differences between dual group versus hCG group in terms of the number of oocytes retrieved (10.0 ± 5.6 vs. 8.7 ± 5.0; P = 0.2816), the number of mature oocytes recovered (8.4 ± 5.0 vs. 7.2 ± 4.0; P = 0.2588), fertilization rate (5.9 ± 4.2 vs. 5.6 ± 3.3; P = 0.7390), and the number of usable embryos on day 3 (4.0 ± 3.0 vs. 4.0 ± 2.4; P = 0.8991). CONCLUSION: The dual trigger is equivalent to hCG in triggering oocyte maturation.http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2016;volume=9;issue=2;spage=101;epage=106;aulast=MahajanDual triggergonadotropin.releasing hormone agonist triggeroocyte maturation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nalini Mahajan Shilpa Sharma Puneet Rana Arora Shalu Gupta Kumkum Rani Padmaja Naidu |
spellingShingle |
Nalini Mahajan Shilpa Sharma Puneet Rana Arora Shalu Gupta Kumkum Rani Padmaja Naidu Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study Journal of Human Reproductive Sciences Dual trigger gonadotropin.releasing hormone agonist trigger oocyte maturation |
author_facet |
Nalini Mahajan Shilpa Sharma Puneet Rana Arora Shalu Gupta Kumkum Rani Padmaja Naidu |
author_sort |
Nalini Mahajan |
title |
Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study |
title_short |
Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study |
title_full |
Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study |
title_fullStr |
Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study |
title_full_unstemmed |
Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study |
title_sort |
evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: a prospective randomized study |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of Human Reproductive Sciences |
issn |
0974-1208 1998-4766 |
publishDate |
2016-01-01 |
description |
BACKGROUND: Mature oocytes are prerequisite for achieving the process of in vitro fertilization. Human chorionic gonadotropin (hCG) is the standard trigger used for stimulating ovulation but is associated with ovarian hyperstimulation syndrome (OHSS). Gonadotropin-releasing hormone agonist trigger achieves oocyte maturation and lowers the incidence of OHSS, but it has limitations of higher pregnancy loss rate and miscarriage rates. Coadministration of both hormones is found to improve the pregnancy rates and the number of mature oocytes retrieved. We aimed to assess if the dual trigger is better than the conventional hCG in triggering oocyte maturation. METHODOLOGY: The study included 76 female patients aged 24–43 years who were randomly divided into two groups with 38 patients in each arm. The study included patients with antimullerian hormone (AMH) <4 ng/ml, antral follicle counts (AFCs)/ovary <12. The study excluded high responders-AMH >4 ng/ml and AFC/ovary >12 to avoid OHSS risk with hCG trigger. RESULTS: The study showed statistically insignificant differences between dual group versus hCG group in terms of the number of oocytes retrieved (10.0 ± 5.6 vs. 8.7 ± 5.0; P = 0.2816), the number of mature oocytes recovered (8.4 ± 5.0 vs. 7.2 ± 4.0; P = 0.2588), fertilization rate (5.9 ± 4.2 vs. 5.6 ± 3.3; P = 0.7390), and the number of usable embryos on day 3 (4.0 ± 3.0 vs. 4.0 ± 2.4; P = 0.8991). CONCLUSION: The dual trigger is equivalent to hCG in triggering oocyte maturation. |
topic |
Dual trigger gonadotropin.releasing hormone agonist trigger oocyte maturation |
url |
http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2016;volume=9;issue=2;spage=101;epage=106;aulast=Mahajan |
work_keys_str_mv |
AT nalinimahajan evaluationofdualtriggerwithgonadotropinreleasinghormoneagonistandhumanchorionicgonadotropininimprovingoocytematurityratesaprospectiverandomizedstudy AT shilpasharma evaluationofdualtriggerwithgonadotropinreleasinghormoneagonistandhumanchorionicgonadotropininimprovingoocytematurityratesaprospectiverandomizedstudy AT puneetranaarora evaluationofdualtriggerwithgonadotropinreleasinghormoneagonistandhumanchorionicgonadotropininimprovingoocytematurityratesaprospectiverandomizedstudy AT shalugupta evaluationofdualtriggerwithgonadotropinreleasinghormoneagonistandhumanchorionicgonadotropininimprovingoocytematurityratesaprospectiverandomizedstudy AT kumkumrani evaluationofdualtriggerwithgonadotropinreleasinghormoneagonistandhumanchorionicgonadotropininimprovingoocytematurityratesaprospectiverandomizedstudy AT padmajanaidu evaluationofdualtriggerwithgonadotropinreleasinghormoneagonistandhumanchorionicgonadotropininimprovingoocytematurityratesaprospectiverandomizedstudy |
_version_ |
1725092293755535360 |